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Abstract
We demonstrate continuous high-throughput selective capture of circulating tumor cells by dielectrophoresis
at arrays of wireless electrodes (bipolar electrodes, BPEs). The use of BPEs removes the requirement of ohmic
contact to individual array elements, thus enabling otherwise unattainable device formats. Capacitive charging
of the electrical double layer at opposing ends of each BPE allows an AC electric field to be transmitted across
the entire device. Here, two such designs are described and evaluated. In the first design, BPEs interconnect
parallel microchannels. Pockets extruding from either side of the microchannels volumetrically control the
number of cells captured at each BPE tip and enhance trapping. High-fidelity single-cell capture was achieved
when the pocket dimensions were matched to those of the cells. A second, open design allows many non-
targeted cells to pass through. These devices enable high-throughput capture of rare cells and single-cell
analysis.
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ABSTRACT: We demonstrate continuous high-throughput
selective capture of circulating tumor cells by dielectrophoresis
at arrays of wireless electrodes (bipolar electrodes, BPEs). The
use of BPEs removes the requirement of ohmic contact to
individual array elements, thus enabling otherwise unattainable
device formats. Capacitive charging of the electrical double layer
at opposing ends of each BPE allows an AC electric ﬁeld to be
transmitted across the entire device. Here, two such designs are
described and evaluated. In the ﬁrst design, BPEs interconnect
parallel microchannels. Pockets extruding from either side of the
microchannels volumetrically control the number of cells
captured at each BPE tip and enhance trapping. High-ﬁdelity
single-cell capture was achieved when the pocket dimensions
were matched to those of the cells. A second, open design allows many non-targeted cells to pass through. These devices enable
high-throughput capture of rare cells and single-cell analysis.
■ INTRODUCTION
In this paper, we report a method for the speciﬁc
dielectrophoretic (DEP) capture of single cells at an array of
wireless bipolar electrodes (BPEs), yielding over 1400 capture
sites. The results of this study demonstrate the utility of BPEs
to enable scalable, high-throughput DEP platforms by
imparting a ﬂexibility in device design that is unparalleled by
conventional electrodes. As a cell separation and isolation tool,
DEP has major advantagesit is label free and highly speciﬁc,
enables single-cell capture, and can provide simple post-capture
access to viable cellsyet it suﬀers from low throughput due to
short-range electric ﬁeld gradients and design constraints. This
shortcoming is a major issue for research and clinical
applications that require large samples to be processed.
Therefore, the current study represents a signiﬁcant funda-
mental advancement in DEP technology. Herein, we
demonstrate the utility of a wireless electrode array for the
isolation of circulating tumor cells (CTCs) based on their
dielectric properties, and we highlight design rules for scaling
and for single-cell capture.
CTCs are cells that have detached from the primary tumor
and migrated into blood vessels. A fraction of these CTCs seed
metastases by extravasation into the parenchyma of foreign
tissues for subsequent growth of tumors. Understanding cancer
spread is critical because metastasis leads to 90% of epithelial
cancer-related deaths,1 and therefore, the study of CTCs is
highly valuable for the development of eﬀective therapies. For
instance, clinical studies have shown that an inverse correlation
exists between patient survival and the number of CTCs that is
independent of line of therapy and, separately, that the
reduction or elimination of CTCs after initial or adjuvant
therapy prolongs survival.2 These ﬁndings indicate that the
enumeration of CTCs is relevant for diagnosis, prognosis, and
evaluation of drug resistance. Additionally, determination of the
genetic mutations harbored by CTCs may provide guidance for
the selection of therapies and personalized treatment.3 Given
these ﬁndings, the isolation and characterization of CTCs are of
paramount importance.
Despite their promise as a clinical indicator and therapeutic
target, the separation of CTCs from whole blood, which is the
ﬁrst inevitable step of overall analysis, is challenging.4 First,
CTCs are extremely rare, such that there can be as few as 1
CTC per 109 erythrocytes and 107 leukocytes.5 In the
CellSearch system, in the standard blood volume of 7.5 mL
employed, the number of CTCs detected normally ranges from
a few cells to several thousand.2,6 Second, due to the
heterogeneous nature of the cell populations found in primary
tumors and the changes undergone by these cells during
metastatic events, the phenotypic characteristics of CTCs can
vary widely. Examples include the nuclear to cytoplasmic ratios
(N/C) (the average N/C ratio of CTCs in breast cancer patients is
4.0,7 while it is 1.43 in prostate cancer patients8), deformability
(CTCs with large N/C ratio are less deformable and less invasive),
size (the size of CTCs reported ranges f rom 4.0 to 30 μm, even
f rom a single patient6), and protein expression (the abundance of
biomarkers such as cytokeratin (CK) and epithelial cell adhesion
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molecule (EpCAM) vary tremendously depending on the patient,
the type of cancer, and the stage of the tumor9).
Despite these challenges, tremendous progress has been
made to target CTCs using one or more of their unique
properties to discriminate them from other cells in blood. The
most prevalent isolation techniques employ immunoaﬃnity
targeting of EpCAM, which is a membrane protein expressed
exclusively by epithelial cells. For example, some prominent
approaches employ antibody-based capture at microchannel
walls10,11 or on magnetic beads (CellSearch, Veridex, Warren,
PA, USA), or sorting of immunoﬂuorescently tagged cells.12,13
Despite its reputation as the only FDA-cleared clinical testing
program, CellSearch and other EpCAM-based approaches
suﬀer from their incapability to capture CTCs that inherently
do not express EpCAM or that have downregulated expression
during acquisition of a more mobile phenotypethe epithelial
to mesenchymal transition (EMT).9 Importantly, the sub-
population of CTCs that have undergone the EMT are most
likely to survive and invade, therefore determining disease
outcome.5 An evidence of the inherent limitation of
immunoaﬃnity techniques is that cultured cancer cells with
high expression of EpCAM, such as MCF7 and SW620 cells
(which have on average 5.0 × 105 and 1.0 × 106 EpCAM
molecules/cell, respectively2,3), must be employed for evalua-
tion of the assay to obtain reliable results. Mitigating with a
cocktail of antibodies increases capture eﬃciency of CTC
subpopulations,14,15 but it is experimentally time-consuming
and cost-ineﬀective and often requires trypsinization and high
ﬂow rate washing to release CTCs captured.10,16
Label-free techniques based on the physical properties of
CTCs circumvent reliance on protein expression so that this
capture bias may be decreased. For instance, ﬁltration
techniques integrate the microscale constrictions of weirs,17,18
pillars,19,20 or pores21−25 into cell separation so that cells with
desired size and deformability can be retained. Clinical
evaluation of these ﬁltration approaches is ongoing.26−28
However, the size distribution of CTCs overlaps with that of
leukocytes, thus resulting in CTC loss or leukocyte
contamination. As a further concern, clogging within ﬁlters
and subsequent change in ﬂow rate may cause shear stress and
potential damage or loss of CTCs. Another label-free
technique, hydrodynamic chromatography, which includes
lateral displacement separation29 and spiral channels,30 imparts
cells in ﬂuids with distinct velocities based on diﬀerences in size
and deformability. Though the throughput is signiﬁcantly
improved relative to ﬁltration (up to 600 mL/h),31 enrichment
becomes poorer due to the inability of these techniques to
diﬀerentiate nucleated cells.32−34
Devices that employ dielectrophoresis (DEP)35−37 are
superior to both immunoaﬃnity and physical isolation
techniques in that they feature antibody-independent separa-
tion and also avoid leukocyte contamination. These advantages
are achieved through the integrated discrimination of both size
and dielectric properties of each cell type. These dielectric
properties arise from the composition and morphology of the
cells and are a much more speciﬁc diﬀerentiator of phenotype
than size alone while not being as overly selective as a single
biomarker such as EpCAM. Therefore, separation based on
DEP exhibits less selection bias when compared with size- and
antibody-based approaches. For instance, Alazzam et al. applied
DEP via interdigitated comb-like electrodes to achieve 96%
capture eﬃciency of MDA-MB-231 cells (an EpCAM-negative
invasive breast cancer cell line) from normal blood cells.38
Gascoyne et al. reported the application of dielectrophoretic
ﬁeld-ﬂow fractionation (DEP-FFF) to isolate three diﬀerent
kinds of tumor cells with above 90% eﬃciency from the
nucleated cell fraction of a blood sample (the “buﬀy coat”).39
Demonstrating the potential of DEP for a high degree of
selectivity, Henslee et al. proved that late-stage breast cancer
cells could be further diﬀerentiated from early and
intermediate-stage CTCs.40 Besides having low selection bias,
DEP is also amenable to downstream analysis of captured cells.
For example, an electroactive double-well array was fabricated
to achieve single-cell DEP capture of PC3 cells, which was
followed by analysis of the intracellular β-galactosidase
activity.41 Despite these advantages, when compared to
ﬁltration and hydrodynamic chromatography, which boast
throughput on the order of 10−100 mL/h,19,31,42 DEP suﬀers
from relatively low throughput in the range of 0.01−1.0 mL/
h.38,40,43 Therefore, the development of high-throughput DEP
devices is critical to their practical application.
Herein, we describe a high-throughput DEP device that is
readily scalable along both x- and y-directions via the
employment of a wireless bipolar electrode (BPE) array, and
we demonstrate its utility for the separation of CTCs from
blood cells using model cell lines. Signiﬁcantly, the BPE array
communicates an AC ﬁeld across insulating barriers (channel
walls) thus enabling the simultaneous capture of CTCs across
parallel microchannels. Micropockets aligned to the BPE tips
and embedded along the wall of each microchannel provide
discrete capture sites with deﬁned volume, thus enabling single-
cell capture. Wireless electrodes are critical to the branching
microchannel scheme employed. Furthermore, to exploit the
capability of DEP-based techniques to retain cell viability,38,39,44
a requirement for the downstream analysis of CTCs such as
culturing and testing of drug eﬃcacy, we demonstrate the full
release of captured cells. A key point is that the ability of DEP
to separate CTCs from blood has been extensively demon-
strated.39,44−47 The features that distinguish the approach
reported here from existing strategies is that it is high-
throughput and capable of high-ﬁdelity single-cell capture.
These features, when combined with on-chip analysis, will
increase understanding of cell-to-cell heterogeneity in tumor
tissue and the related clinical outcomes.
■ THEORETICAL BACKGROUND
Bipolar Electrodes (BPEs) in Microﬂuidic Devices. A
bipolar electrode (BPE)48−50 is a conductor in an ionically
conductive phase that when exposed to an external electrical
ﬁeld can facilitate oxidation and reduction reactions simulta-
neously at opposite ends. For example, a BPE can comprise a
strip of metal embedded in a microﬂuidic channel ﬁlled with an
aqueous electrolyte. When a DC electric potential is applied
across the reservoirs of the microchannel, a linear potential
drop is expected along the channel length due to its high
electrical resistance. This linear electric ﬁeld leads to potential
diﬀerences between the BPE (an equipotential object) and the
solution in contact with its ends. An electrical double layer
(EDL) forms at each end of the BPE, and faradaic reactions
occur if the potential diﬀerences at the BPE/solution interface
(cathode and anode) provide suﬃcient overpotential to drive
simultaneously the reduction and oxidation of available redox
species. Scheme 1a depicts a BPE situated along the ﬂoor of a
microﬂuidic channel. An equivalent circuit that describes this
system is shown at bottom left ((b) in Scheme 1). In this
microchannel, current ﬂows between the driving electrodes
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either via ionic conduction in solution or through the BPE via
capacitive charging or charge transfer (faradaic reactions) ((c)
and (d) in Scheme 1). The solution resistance (to ionic
current) is represented by Rs1 (left of BPE), Rs2 (above BPE),
and Rs3 (right of BPE). Rct is the resistance to charge transfer
reactions, whereas Cdl1 and Cdl2 are the double layer capacitance
at each end of the BPE. This conﬁguration has been employed
most prevalently to achieve faradaic reactions (current through
Rct) without making direct ohmic contact to the BPEs, and
many applications take advantage of the ability of BPEs to be
arrayed. For example, Crooks and co-workers designed a BPE
array composed of 1000 individual BPEs to facilitate faradaic
reactions. They employed electrogenerated chemiluminescence
(ECL) at the anode to report the activation of a sensing event
at the cathode.51 The ECL intensity proﬁle indicated a uniform
response from each BPE under the applied DC electric ﬁeld. A
wide range of applications52−59 hitherto bears testimony to the
fact that BPEs are eﬀective, convenient, and robust for the
detection, sensing, separation, and enrichment of a wide variety
of analytes.
However, when a suﬃciently high frequency AC ﬁeld is
applied rather than a DC electric ﬁeld, faradaic reactions do not
occur (Rct approaches inﬁnity when the ﬁeld frequency is
greater than the rate of electron transfer from available redox
species). Further, if the top of the microchannel meets the BPE,
then the possibility of ionic current above the BPE is removed
(Rs2 becomes inﬁnite). In this scenario, the continuous charging
and discharging of the EDL formed between each end of a BPE
and the solution (Cdl1 and Cdl2) becomes the primary route by
which the electric ﬁeld drives current between the driving
electrodes.
Due to this capacitive charging, separate parallel micro-
channels can remain electrically interconnected by the
embedded BPEs in an AC electric ﬁeld. Scheme 2 depicts the
parallel channel device layout (a, side view and b, top view), the
corresponding equivalent circuit (c), an illustration of the
location of the double layer capacitance at each BPE tip (d, side
view), and a 2D simulation of the electric ﬁeld distribution
across a single microchannel ﬂanked by 6 BPE tips (e, top
view). Due to the equipotential quality of conductors, each BPE
takes on a potential that is intermediate to the potential of the
solution in contact with its ends, and then a drop in potential
(electric ﬁeld) is distributed across the solution in each
microchannel. This electric ﬁeld distribution can be readily
tuned by the dimensions of the BPEs. For instance, pointed
BPEs result in a maximum electric ﬁeld at the BPE tip, while
minimum ﬁeld intensity is located at the middle of the channels
(Scheme 2e). In this way, the BPEs not only transmit the AC
electric ﬁeld across the chip, but also shape the electric ﬁeld in a
desired way.
DEP Manipulation of Cells. DEP is a ﬁeld-induced force
(FDEP) acting on a polarizable particle when exposed to a non-
uniform electric ﬁeld.60,61 The external electric ﬁeld (E) induces
the surface charges (bound and free charges) to accumulate at
the particle-medium interface. The gradient in the electric ﬁeld
exerts diﬀerential force on the two opposing ends of the
resulting induced electrical dipole, which in turn leads to a net
dielectrophoretic force. The time-averaged DEP force experi-
enced by a homogeneous spherical particle with radius r in a
medium of permittivity εm is given by
π ε ω⎯ →⎯⎯⎯ = ∇⃗ | ⃗|F r K E2 Re[ ( )]DEP 3 m 2
where Re[K(ω)] is the real part of Clausius−Mossotti factor,
ω
ε ε
ε ε
=
* − *
* + *
K( )
2
p m
p m
which determines the direction and relative strength of DEP
force as a function of applied ﬁeld frequency. Here, εp* and εm*
are the frequency-dependent complex permittivities of the
particle and medium, respectively. When Re[K(ω)] is positive,
the induced DEP force, displaces particles toward higher
electric ﬁeld (positive DEP (pDEP)), while particles move
toward lower electric ﬁeld when Re[K(ω)] is negative (nDEP).
The frequency above which cells transition from an nDEP to
pDEP response is the crossover frequency (cof). Importantly,
the unique frequency-dependent polarization responses of
biological cells allow them to be separated by DEP at a ﬁeld
frequency and medium conductivity where signiﬁcantly
disparate values of Re[K(ω)] can be achieved for each. For
example, for the model cell lines employed in the current study,
it is reported that MDA-MB-231 (breast cancer) cells
experienced pDEP at frequencies greater than 45−85 kHz in
a medium with conductivity of 30 mS/m,44 while the cof is
110−190 kHz for Jurkat E6-1 T cells (a model white blood cell
line) in a medium with a conductivity of 40 mS/m.62
Therefore, separation of these cell types is anticipated between
45 kHz and 110 kHz in a similar medium. An increase in
Scheme 1. Illustration of the Functions of a BPE in a DC
Electric Field
Scheme 2. Illustration of the BPEs in a Parallel-Channel
Device under an Applied AC Electric Field
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medium conductivity will result in an increase in the frequency
required for separation, and eventually, in an inability of any
cell type to achieve crossover to pDEP.63 For this reason, as is
common practice in DEP techniques, cells are suspended in a
low conductivity isotonic medium to achieve separation.
■ MATERIALS AND METHODS
Chemicals. The silicone elastomer and curing agent (Sylgard 184),
bovine serum albumin (BSA) (biotech grade), and 0.25% Trypsin-
EDTA (1X) were purchased from Fisher Scientiﬁc (Thermo Fisher
Scientiﬁc, Inc., Waltham, MA). The DMEM/F12 cell culture medium,
dextrose (D-glucose), sucrose, Pluronic F-108 and 1.0 M Tris·HCl
stock were obtained from Sigma-Aldrich, Inc. (St. Louis, MO). The
RPMI 1640 medium was purchased from American Type Culture
Collection (ATCC) (Manassas, VA). All dilutions were conducted
with Type 1 water (18.2 MΩ·cm). DEP buﬀer was comprised of 8.0%
sucrose, 0.3% dextrose, and 0.1% BSA in 1.0 mM Tris buﬀer (pH =
8.1).
Cell Culture. MDA-MB-231 and Jurkat E6-1 T cells were obtained
from ATCC. They were cultured in DMEM/F12 and RPMI 1640
media, respectively, with 1% pen-strep and 10% fetal bovine serum
supplementation at 37 °C and 5% CO2. All cells were subcultured
every 2−3 days to maintain the concentration of cells at less than 1.0 ×
106 cells/mL. In preparation of DEP experiments, MDA-MB-231 cells
were detached from culture ﬂask using 0.25% Trypsin-EDTA (1×),
followed by pelleting by centrifugation (1100 rpm, 5 min) and
resuspension in 5.0 mL Tris DEP buﬀer. Jurkat E6-1 T cells were
directly pelleted from culture medium prior to resuspension in DEP
buﬀer. Pelleting and resuspension was repeated to wash cells twice in
DEP buﬀer before DEP capture experiments.
DEP Experiments. All the devices were designed to operate such
that the cells, suspended in DEP buﬀer, were ﬂowed through and
either attracted to and captured at BPE tips (pDEP) or retained in
ﬂuid ﬂow (nDEP). Device operation was accomplished by the
application of an AC voltage at coplanar driving electrodes at each side
of the BPE arrays using a Tektronix AFG3011C waveform generator
(Tektronix, Beaverton, OR) and Trek model 2205 ampliﬁer (Trek,
Lockport, NY). The AC frequency was maintained at 40 kHz at which
MDA-MB-231 cells experienced strong pDEP, while Jurkat E6-1 T
cells exhibited nDEP. Nikon eclipse Ti inverted microscope and Nikon
AZ-100 microscope (Nikon, Tokyo, Japan) were utilized to image cells
to obtain ﬂuorescence and optical images, respectively.
Device Dimensions. The dimensions for two device designs are
described here (The complete drawings are shown in the Supporting
Information). For the high-throughput parallel-channel design, 32
microchannels with each being 2.95 mm long × 200 μm wide × 25 μm
tall were arranged in parallel and separated by 0.486 mm (center-to-
center). Each channel had 22 pockets extruded at each side (1408
pockets). Each pocket was 40 μm long × 40 μm wide and the edge-to-
edge distance of two adjacent pockets was 80 μm. The microchannels
were interconnected to a common inlet and outlet by a bifurcation
(branching) scheme. A tapered channel inlet with an array of
diamond-shaped pillars (100 μm × 40 μm) facilitated introduction of
cells into the channels. The electrodes extend into the pockets from
under the PDMS to a distance of 10 μm from the channel. The two
rows of electrodes at the ends (outermost channels) were
interconnected and led to contacts for the waveform generator.
The following modiﬁcations were then made to the parallel-channel
photomask design in the drawing software to create the open-channel
design. Importantly, the BPE array layout was unchanged. First, groups
of 8 microchannels were merged by deleting the interior channel walls.
This resulted in four 3.6 mm-wide chambers interconnected with
BPEs. Second, pillars with a radius of 20 μm were added at the center
of each BPE to support the ceiling of these chambers. Finally, the
bifurcated channels were edited to connect each chamber to inlet and
outlet reservoirs. Consequently, the separation area of the open-
channel design doubled compared to the parallel-channel design in the
same device footprint.
■ RESULTS AND DISCUSSION
The traditional electrodes38,44,64,65 widely employed in DEP
limit the extension and ﬂexibility of device design because the
electrodes have to be connected via wire leads to the power
source. For example, the bifurcated channels employed in the
current study would intersect electrodes, leading to unwanted
cell capture and clogging in the inlet channels. Our results
demonstrate the capability of a BPE array to enable wireless
control of the distribution of an AC electric ﬁeld while
alleviating design constraints.
DEP characterization of Two Model Cell Lines. To test
the ability of our BPE array-based device to separate CTCs
from other cells in the blood, two model cell lines were
employed. The DEP responses of MDA-MB-231 (breast cancer
cells) and Jurkat T-cells (white blood cells) were characterized
using quadrupole electrodes as follows to determine an AC
electric ﬁeld frequency at which the two cell types could be
separated. The conductivity of the DEP buﬀer used in the
present work was 6.2 mS/m. The quadrupole electrode design
was guided by simulation of the resulting electric ﬁeld using
COMSOL simulation software (Multiphysics 5.2a, COMSOL,
Inc., Burlington, MA) (Figure 1a). The design was found to
provide a suﬃcient electric ﬁeld gradient to allow nDEP and
pDEP responses of the cells to be distinguished. Cells
undergoing nDEP move to the center of the quadrupole
design at which the electric ﬁeld is at a minimum. In contrast, a
Figure 1. Determination of the separation frequency using quadrupole electrodes. (a) Results of the simulation of the electric ﬁeld (E (V/m)) in the
center of the quadrupole design. The center region exhibits a local minimum electric ﬁeld, and the maximum ﬁeld is located along the electrode
edges. (b) pDEP of MDA-MB-231 cells at 40 kHz. (c) nDEP of Jurkat E6-T cells at 40 kHz.
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pDEP response is characterized by cells moving to the
electrode edges, where the electric ﬁeld is strongest. To
determine the response of each model cell line, 100 μL of the
cell sample (1 × 106 cells/mL in DEP buﬀer) were applied to
the quadrupole electrodes, and the frequency of the AC voltage
(10.0 Vpp) applied between opposing electrode pairs was swept
from 1 kHz to 100 kHz (further experimental details are
available in the Supporting Information in Figure S1). Based on
the results shown in Figure 1, 40 kHz was chosen for separation
as MDA cells experienced strong pDEP and Jurkat cells
underwent an nDEP response.
Simulation of the Electric Field in the BPE Array-
Based DEP Devices. Two designs that employ BPEs to shape
the AC electric ﬁeld were fabricated and investigated. In both
designs, cells experiencing pDEP were expected to be trapped
at the electric ﬁeld maxima around the BPE tips, while cells
undergoing nDEP remain in ﬂuid ﬂow. The inﬂuence of the
device dimensionality in terms of the shape, arrangement and
tip position of the BPEs on the electric ﬁeld were simulated and
optimized using the ﬁnite element method (COMSOL
Multiphysics 5.2a) (details of the simulation and optimization
process are available in the Supporting Information). The
distribution of the electric ﬁeld and the DEP force along a line
trace intersecting the central axis of the BPEs in the two
optimized devices are shown in Figure 2. In the simulation, the
dimensions (e.g., channel width, pocket size and BPE tip
position and shape) matched those of devices employed in the
experiments. The spatially and time-averaged electric ﬁeld
(Eavg,rms) was 13.7 and 6.0 kV/m for the parallel-channel and
open-channel designs, respectively. These values correspond to
an applied voltage of 248 Vpp, which was employed in
experiments. Figure 2a,b shows the resulting electric ﬁeld
distribution in each design, and Figure 2c,d plots the electric
ﬁeld strength along cut-lines bisecting a row of BPEs. The
maximum electric ﬁeld strength is located at the BPE tips and is
approximately 38 and 34 kV/m for the parallel-channel and
open-channel designs, respectively. Figure 2e,f shows an
estimate of the pDEP force experienced by a 12.0-μm-radius
cell as a result of this electric ﬁeld (Re[K(ω)] = 1.0). We can
make several conclusions based on these data. First, we can
conclude that the DEP force exerted by this electric ﬁeld is
suﬃcient for cell trapping. A force of 5.0−15 pN is suﬃcient to
Figure 2. Numerical simulation of the electric ﬁeld strength (a−d) and DEP force (e,f) in the parallel-channel design (a,c,e) and open-channel
design (b,d,f). Inset of (e) shows detail of the DEP force at distances greater than 54 μm from the BPE tip (x = 446 μm).
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overcome drag force experienced by an MDA cell trapped in
ﬂuid ﬂowing past at linear velocities in the range employed in
the experiments reported here. Importantly, pDEP forces
greater than this threshold extend up to 50 μm from each BPE
tip (inset of Figure 2e, BPE tip located at 446 μm). This result
is signiﬁcant because it indicates that channels wider than 100
μm will experience a decrease in capture eﬃciency as channel
width increases.
Second, the results in Figure 2 demonstrate the impact of
increasing the radius of curvature of the BPE tips on the electric
ﬁeld distribution. In comparison to the fully pointed tips shown
in Scheme 2, these rounded tips distribute the strongest region
of the electric ﬁeld over a broader area, thereby preventing the
damage to cells that may be incurred by an overly focused
electric ﬁeld. Next, we can compare the features of the electric
ﬁeld in the two device designs. Considering the electric ﬁeld
distribution in the open-channel design (Figure 2, right side),
the ﬁeld strength around the junctions between the large open
chambers (34 kV/m) is 35% higher than that toward the
middle of the chambers (22 kV/m). Thus, more cells were
expected to be trapped around the junctions. In contrast, the
electric ﬁeld proﬁle is uniformly distributed across the parallel
channels, therefore a uniform distribution of trapped cells can
be expected. Finally, as an added design feature, in the parallel-
channel device, a 10 μm gap was introduced between the tip
and the micropocket opening to prevent captured cells from
being pulled away by the ﬂowing DEP buﬀer. Therefore, while
the open-channel design enables higher sample throughput, the
parallel-channel design oﬀers more uniform ﬁeld distribution,
more robust capture, and control over the number of cells
captured at each BPE tip as deﬁned by the micropocket
geometry.
DEP Separation of Cells at an Array of Wireless
Electrodes. The separation performance of the wireless
electrode (BPE) array in the parallel-channel and open-channel
was studied using Jurkat E6-1 T and MDA-MB-231 as model
white blood cells (WBCs) and CTCs, respectively. First, a
Pluronic-treated device was rinsed with DEP buﬀer for 15 min.
Second, an AC signal (248 Vpp, 40 kHz) was applied at the
driving electrodes. Under these conditions, the average electric
ﬁeld strength (Eavg,rms) in the trapping channels (between
BPEs) was 13.7 and 6.0 kV/m for the parallel-channel and
open-channel devices, respectively. The solution in the inlet
reservoir was then replaced with the cell sample in DEP buﬀer,
and a height diﬀerential was established between the inlet and
outlet reservoirs to achieve a desired ﬂuid ﬂow in the trapping
channels. Optical images showing the response of the MDA-
MB-231 cells in the two designs are shown in Figure 3a−c. The
images obtained in Figure 3a was taken after the cells were
allowed to be trapped under an average linear ﬂow velocity of
80 μm/s in the parallel-channel device for approximately 5 min.
Complete release of cells was achieved by turning oﬀ the AC
ﬁeld and gradually increasing the ﬂow rate. Likewise, Figure 3b
shows the result of an experiment performed under the same
conditions in the open-channel device with the exception that
the average linear ﬂow velocity was 20 μm/s. This decreased
ﬂow rate was required in the absence of micropockets to obtain
reliable cell capture. In both cases, the successful capture of the
MDA cells is signiﬁcant because it demonstrates the operation
of a DEP device with a wireless BPE array. More speciﬁcally,
the results show that the capacitive charging of the EDL at the
BPE tips transmits the AC ﬁeld across the device and provides
suﬃcient electric ﬁeld gradients to exert DEP trapping force.
In addition, it was observed that some of the MDA cells
trapped in the open-channel design were washed away when
Figure 3. Optical micrograph of DEP responses of MDA-MB-231 and Jurkat E6-1 T cells at 40 kHz in the two device designs. (a) pDEP response of
MDA-MB-231 cells in the parallel-channel design (the applied electric ﬁeld is 13.7 kV/m, the frequency is 40 kHz and the linear ﬂow velocity is 80
μm/s). (b,c) pDEP response of MDA-MB-231 cells in the open-channel design in an electric ﬁeld of 6.0 kV/m and 40 kHz and a linear ﬂow velocity
at (b) 20 and (c) 50 μm/s. (d) nDEP response of Jurkat E6-1 T cells in the parallel-channel design under the same electric ﬁeld and linear ﬂow rate
conditions employed in (a). (e,f) nDEP response of Jurkat E6-1 T cells in the open-channel design when (e) 10.9 and (f) 13.3 kV/m was applied.
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the linear ﬂow velocity was increased from 20 to 50 μm/s
(Figure 3c). This feature can be exploited to control the
maximum number of cells captured at each BPE tip. According
to the simulations shown in Figure 2c,e, the DEP force in the
parallel-channel design is about 2-fold higher than that in the
open-channel design, while the ﬂow rate tolerated by trapped
cells was about 4-fold higher. Therefore, though the total
separation channel width is doubled in the open-channel
design, the limitation on accessible ﬂow rates eventually results
in an overall decrease in throughput. On the other hand, full
release of the captured cells was easier to achieve in the absence
of pockets. These results are signiﬁcant because they
demonstrate that micropockets provide secure capture, while
open chambers simplify recovery and downstream analysis.
Under similar conditions, the Jurkat E6-1 T cells underwent
an nDEP response in which they were repelled from the BPE
tips and formed “pearl chains” (Figure 3d−f). Figure 3d is an
optical image of the cells ﬂowing through the parallel-channel
device under an applied voltage of 248 Vpp. Figure 3e,f shows
the response of Jurkat cells in the open-channel device at an
applied voltage of 444 and 543 Vpp, respectively. These higher
ﬁeld strengths were employed to more clearly demonstrate the
weak nDEP response. This weak nDEP response of the Jurkat
cells is expected because the maximum nDEP force occurs
when Re[K(ω)] = −0.5, while it can reach +1.0 for pDEP. We
can draw two primary conclusions from these results. First, at
40 kHz, Jurkat cells remained in ﬂow, and therefore, the clear
discrimination of the DEP responses for the two types of cells
at 40 kHz indicated that the frequency is suﬃcient for
separation. Second, for the open-channel design, Jurkat cells
could be repelled to either of two regions of the chambers with
a low electric ﬁelddirectly above the center line of the BPEs
or along the midline between BPEs. This feature is favorable for
separation of CTCs from blood because it provides more paths
for the large number of blood cells to pass through.
Scaling Strategies. An important advancement aﬀorded by
BPEs is the facile scaling of DEP-based devices. When BPEs are
arranged in an open-channel design, an applied voltage at the
chamber walls results in a linear potential drop along the width
of the chamber. The potential diﬀerence between the opposite
ends of the BPEs (ΔUelec) can then be estimated by
Δ =U l
n w
Uelec
elec
ch ch
tot
(1)
where Utot represents the applied potential across a microﬂuidic
device; nch, wch, and lelec are the number of chambers, the width
of an individual chamber, and the length of the BPEs,
respectively.
Using eq 1, ΔUelec can thus be estimated to be 5 Vpp when
the driving voltage is 248 Vpp (nch = 4, wch = 3.6 mm, and lelec =
0.286 mm). Considering that the magnitude of ΔUelec relates to
the ability of the BPE to locally perturb the electric ﬁeld, ΔUelec
can be utilized as a parameter for scaling in the open-channel
design. Importantly, while such potential diﬀerences between
opposing ends of a BPE can drive faradaic reactions in a DC
ﬁeld, the AC ﬁeld employed for DEP allows much higher
potential diﬀerences without initiating unwanted electron
transfer.66
When each BPE is bisected by an insulating wall, as is the
case in the parallel-channel design, the barriers lead to a
discontinuous/stepped potential proﬁle. The time-averaged
electric ﬁeld (Erms) and DEP force in parallel channels of width
200, 100μm, and 50 μm were evaluated by numerical
simulation. In comparison with a 200-μm-wide parallel-channel
device, the 100 and 50 μm channels required a higher ﬁeld
strength to achieve a similar DEP force (930 pN). The spatially
and time-averaged electric ﬁeld of Eavg,rms = 13.7 kV/m required
to achieve this force in the 200 μm channels increased to 17.8
kV/m (130% increase) and 26.0 kV/m (190% increase),
respectively. This requirement arises from a decrease in the
ﬁeld gradient (∇|E|) as the channel width decreases.
Consequently, Eavg,rms has to be increased to oﬀset the
attenuation of ∇|E|. These simulations were compared with
experimental results for the pDEP capture of MDA-MB-231
cells in 100- and 50-μm-wide parallel-channel devices.
Independent from the simulations, the inﬂuence of geometrical
parameters such as channel length and BPE length on the
electric ﬁeld were also evaluated.
Table 1 lists the geometrical and electric ﬁeld parameters for
six separate parallel-channel device layouts that demonstrated
similar DEP force in MDA-MB-231 capture experiments. Note
that for Table 1, parameters to be compared within a column
are in bold. Further, channel length and number of pockets were
scaled together and are considered as one parameter. These
experimental results corroborate the conclusions of the
simulations, i.e., when a potential was applied to yield the
calculated value of Eavg,rms, MDA cells could be successfully
trapped. Importantly, as was predicted by the simulations, a
lower Eavg,rms could be applied in a wider channel to achieve
suﬃcient DEP capture force. In addition, the following
conclusions can be made: (i) Extension of the length of the
BPE under the insulating wall has no eﬀect on the applied
voltage (Vpp) required for cell capture, a result which can be
ascribed to the extremely low electric resistivity of gold metal
(22.14 nΩ·m at 20 °C). (ii) Extending the channel length (to
add a proportional number of micropockets) also has no impact
on the applied voltage since this extension is equivalent to
adding resistors in parallel. (iii) Doubling the number of
parallel channels doubles the applied voltage required for
capturing MDA cells. This increased electric ﬁeld results from
the addition of the number of resistances in series. The
consistency of the simulation with the experimental data
demonstrates that the parallel-channel design can be optimized
following straightforward scaling rules. Most importantly, the
route to increased throughput is to minimize BPE length and to
add more parallel channels (i and iii above). Capture eﬃciency
is likewise easily improved by extending the channel length (ii
above) and the number density of pockets.
Demonstration of Selective Capture of Cancer Cells.
The ﬂuorescence micrographs in Figure 4 demonstrate the
selective capture of model breast cancer cells from a mixture of
both MDA (green) and Jurkat cells (yellow). In this
experiment, the dye-linked antibody-labeled cells were
Table 1. Scaling Rules in the Parallel-Channel Device
channel
width
(μm)
no. of
channels
BPE
length
(μm)
channel length
(μm) (no. of
pockets)
applied
voltage
(Vpp)
Eavg,rms
(kV/
m)
200 32 2.86 2.56 (22) 248 13.7
100 4 2.86 2.56 (22) 20.2 17.8
100 4 8.00 2.56 (22) 20.2 17.8
100 8 2.86 2.56 (22) 40.3 17.8
100 8 2.86 5.20 (44) 40.3 17.8
50 4 2.86 2.56 (22) 15.0 26.0
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combined in DEP buﬀer to a ﬁnal concentration of 5.0 × 105
MDA cells/mL and 1.0 × 106 Jurkat cells/mL. Considering the
extremely low concentration of CTCs encountered in clinical
practice, a representative sample would not clearly demonstrate
the function of the present approach. For instance, only ﬁve
CTCs would be captured in 1.0 h if the concentration of CTCs
were 50 CTCs/mL, yielding ambiguous results, especially
regarding the ﬁdelity of single-cell capture. Therefore, a high
concentration of CTCs was employed here with the view that
the observed behavior could be extended to fewer cells.
Importantly, evaluation of capture eﬃciency in the recovery of
rare cells is forthcoming. We anticipate that the capture of
CTCs at concentrations representative of what is observed in
clinical practice is feasible. The challenges posed by these low
concentrations are shared by all other CTC isolation
schemesnamely, avoidance of cell loss during sample
preparation and longer run times. In the parallel-channel
design, the mixed cell sample was ﬂowed into the device at an
average linear velocity rate of 60 μm/s, and a 40 kHz AC ﬁeld
was applied. After allowing the MDA cells to be trapped at the
BPE tips, ﬂuorescence images for each dye (Alexa 488/green
and phycoerythrin/yellow) were taken in rapid sequence and
overlayed to obtain the image shown in Figure 4a,b. As shown
in Figure 4, only breast cancer cells (green) were trapped and
accumulated at the BPE tips, while the white blood cells
(yellow) ﬂowed past. Similar results were obtained in the open-
channel device with the exception that a much lower ﬂow rate
(20 μm/s) was required to allow capture of MDA cells (Figure
4c,d). These results are signiﬁcant because they demonstrate
the selective capture of breast cancer cells from white blood
cells in a high-throughput DEP device at an array of wireless
electrodes.
Demonstration of Single-Cell Capture by Geometric
Constraint in the Parallel-Channel Device. CTCs have
shown clinical importance for determining prognosis and for
guiding therapeutic decisions.67,68 However, due to the cellular
heterogeneity among CTCs from an individual patient,
molecular analyses using collective cell samples can only
provide averaged data, which may obscure critical information
about subpopulations.69,70 To obtain a complete picture of the
genetic variability extant in tumor tissue, the development of
single-cell isolation techniques becomes essential. To test the
ability of the parallel-channel device to achieve single-cell
capture by geometric constraint, we decreased the pocket size
from 40 μm long × 40 μm wide to 30 μm long × 25 μm wide.
Pearl-chaining of cells can occur when there is insuﬃcient drag
force competing with the DEP capture force, and therefore,
selective single-cell capture of MDA-MB-231 cells from Jurkat
E6-1 T cells was evaluated under various ﬂow rates. After MDA
cells were captured under each ﬂow rate for approximately 5
min, images were taken and the number of MDA cells at each
pocket along four parallel channels was counted and averaged.
According to the results shown in Figure 4, it can be concluded
that (i) The present device is robust in selectively isolating
single cells under various ﬂow rates. (ii) Over 80% of pockets
obtained individual MDA cells when the ﬂow rate was less than
50 μm/s. Increasing the ﬂow rate beyond 50 μm/s decreased
the likelihood of trapping multiple cells per chamber; (iii)
Figure 4. Demonstration of the capability of selective capture in both designs, and single-cell capture in a parallel-channel device with decreased
pocket size. In all the ﬂuorescent micrographs, 40 kHz AC electric ﬁeld was applied to a mixture of the two cell types (MDA-MB-231 (green) and
Jurkat (yellow)), in which MDA-MB-231 cells were labeled with Alexa Fluor 488 anti-human EGFR antibody, and Jurkat cells were labeled with PE
anti-human CD45 antibody. The response was recorded after the AC voltage was applied for (a) 1 and (b) 3 min in the parallel-channel design and
for (c) 1 and (d) 3 min in the open-channel design. (e) Fluorescent micrograph showing the capture of single MDA-MB-231 cells (green) after 3
min of AC ﬁeld application in the modiﬁed parallel-channel design. (f) Plot of the single-cell capture performance at three average linear ﬂow
velocities (n = 3).
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Regardless of ﬂow rate, multi-cell capture was rare (<2%) using
the current design. A key point is that the single-cell capture
rate is far better than can be achieved by randomly partitioning
the sample, for which Poisson statistics predicts that when 37%
of pockets contain a single cell, there will also be 37% empty,
18% with double occupancy and 7% containing three or more.
Further, our design leaves open the option to capture cells
under a slow ﬂow rate and to subsequently disrupt multiple
occupancies by increasing the ﬂow rate. It is worth mention
that the 10 μm gap between the BPE tip and the micropocket
opening plays a crucial role in capturing and stabilizing single
cells. The strategy demonstrated here not only meets the
challenge of high-throughput and selective CTC isolation by
DEP, but also enables single-cell capture. In subsequent studies,
we aim to exploit electrochemistry at individual BPEs and to
adapt micropocket geometry to accomplish on-chip analysis of
individual cells.
■ CONCLUSION
DEP-based techniques are advantageous for the isolation of
CTCs because they do not suﬀer from the same bias as
immunoaﬃnity-based techniques but are more selective than
capture based on physical properties of cells alone. However,
DEP devices generally suﬀer from low volumetric throughput,
which is especially problematic for rare cells, such as CTCs. We
have demonstrated that the integration of wireless electrodes
allows for the creation of DEP devices that are easily scalable
along the x- and y-directions. Additionally, removing the need
for wire leads enables device architectures, such as branching
microchannels, which further increase throughput. Using the
parallel-channel design reported here, about 0.1 mL/h
throughput could be achieved with a 39.6 mm2 device footprint.
If the device were scaled to 7500 mm2, the footprint of a
previously reported DEP device, a throughput of 18.9 mL/h
would be anticipated.39 Even if the device were scaled to 2.21 ×
103 mm2, the footprint of the ApoStream device reported,44 the
throughput would still be over 5.5 mL/h. In this scenario, we
expect that 1.0 mL of blood could be processed in
approximately 11 min. In addition, assuming 1−100 CTCs/
mL of whole blood, the present parallel-channel device can
process the standard volume (7.5 mL) employed in the
commercial CellSearch system, without exhausting the 1408
capture sites (in the 40 mm2 device). If a buﬀy coat from 1.0
mL of blood suspended to 100 μL of DEP buﬀer is utilized, a
10-fold decrease in separation time can be expected.
Furthermore, due to the incorporation of micropockets into
the parallel-channel design, single-cell capture was readily
achieved by adjusting the size of the pockets to the size of the
targeted cells. The present BPE array-based designs exhibit
signiﬁcant advancements in DEP technology, including wireless
control of the AC ﬁeld and enhanced design ﬂexibilitywhich
led to increased throughput and high-ﬁdelity parallel single-cell
capture. These advancements are made while retaining the
inherent advantages of DEP, including selective and label-free
isolation of cells and ease of fabrication, which provide an
avenue to utilize the devices for point-of-care applications.
Further evaluation of the capture eﬃciency and the perform-
ance of the technique in clinical samples are in progress in our
laboratory.
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